Catalyst Wire Dossier Catalyst Wire Dossier

Filgrastine

Filgrastine · Blau Farmaceutica S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Filgrastine, covering 2023-03-29 to 2023-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy [Phase 3]

See pricing